Cost of acute coronary syndrome in Switzerland in 2008

Wieser, Simon; Rüthemann, Isabelle; Boni, Sylvia Nadine De; Eichler, Klaus; Pletscher, Mark; Radovanovic, Dragana; Ulle, Tanja; Auerbach, Holger

doi:10.4414/smw.2012.13655

Cited by 17 publications

(31 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For instance, Wieser et al (2012) estimate that in 2008 the total direct costs of acute coronary syndrome (of which AMIs represent more than 80% of the costs) were more than 1 billion Swiss…”

Section: Resultsmentioning

confidence: 99%

Short Term Effects of Public Smoking Bans on Health

Mazzonna

Salari

2015

SSRN Journal

View full text Add to dashboard Cite

This paper evaluates the causal negative effect of environmental tobacco exposure on health by exploiting the time and geographical variation in public-place smoking bans implemented in Switzerland between 2007 and 2011. Using monthly data from the universe of Swiss hospitals between 2004 and 2012, we show that the incidence of acute myocardial infarction hospitalizations decreases by about 10-12% immediately after the law implementation. We also find evidence of heterogeneity by age and sex and across income and education groups. In particular, the policy affected mainly men aged 50+ and the regions characterized by a lower level of income and education.

show abstract

Section: Resultsmentioning

confidence: 99%

Short Term Effects of Public Smoking Bans on Health

Mazzonna

Salari

2015

SSRN Journal

View full text Add to dashboard Cite

show abstract

“…-бюджетные потери в связи с реабилитацией и вре-менной/полной потерей трудоспособности; -расходы при повторном стентировании/КШ [14,28,32,40,49,54,60].…”

Section: кардиология и сердечно-сосудистая хирургия 2 2015unclassified

“…США [60]. Стоимость лечения ОКС и последующих затрат в те-чение 1-го года составляли к 2007 г.: в Великобритании -1,9 млрд евро; во Франции -1,3; в Германии -3,3; в Ита-лии -3,1; в Израиле -1; в Швейцарии -630 млн швей-царских франков [49,54].…”

Section: кардиология и сердечно-сосудистая хирургия 2 2015unclassified

“…По данным Winterthur Institute of Health Economics (2012), 45,8 и 35,8% годовых затрат приходилось на груп-пы с STEMI и NSTEMI соответственно [54]. Бюджетные потери от повторных госпитализаций (20%) в 1-й год по-сле медикаментозной терапии, стентирования/КШ со-ставили 45,3, 41,2 и 43,5% соответственно [40,60].…”

Section: кардиология и сердечно-сосудистая хирургия 2 2015unclassified

“…[32]. Экономический ущерб от временной (60%) и полной (5%) инвалидизации у больных составлял примерно 20% ежегодных затрат [54].…”

Section: кардиология и сердечно-сосудистая хирургия 2 2015unclassified

See 2 more Smart Citations

Features of ischemic heart disease and myocardial revascularization in patients younger than 40 years

Abdullaev¹,

Mamedov²,

Багиров³

et al. 2015

Kardiol. serdechno-sosud. khir.

View full text Add to dashboard Cite

Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome

et al. 2020

View full text Add to dashboard Cite

Background Person-centred care has been shown to be cost-effective compared to usual care for several diseases, including acute coronary syndrome, in a short-term time perspective (< 2 years). The cost-effectiveness of person-centred care in a longer time perspective is largely unknown. Objectives To estimate the mid-term cost-effectiveness of person-centred care compared to usual care for patients (< 65) with acute coronary syndrome, using a 2-year and a 5-year time perspective. Methods The mid-term cost-effectiveness of person-centred care compared to usual care was estimated by projecting the outcomes observed in a randomized-controlled trial together with data from health registers and data from the scientific literature, 3 years beyond the 2-year follow-up, using the developed simulation model. Probabilistic sensitivity analyses were performed using Monte Carlo simulation. Results Person-centred care entails lower costs and improved effectiveness as compared to usual care, for a 2-year time and a 5-year perspective. Monte Carlo simulations suggest that the likelihoods of the person-centred care being cost-effective compared to usual care were between 80 and 99% and between 75 and 90% for a 2-year and a 5-year time perspective (using a 500,000 SEK/QALY willingness-to-pay threshold). Conclusions Person-centred care was less costly and more effective compared to usual care in a 2-year and a 5-year time perspective for patients with acute coronary syndrome under the age of 65.

show abstract

Cost of acute coronary syndrome in Switzerland in 2008

Abstract: ACS causes considerable costs in terms of direct medical expenditures, lost production, suffering and premature death, even without taking into account costs for its chronic consequences such as congestive heart failure.

Cited by 17 publications

References 17 publications

Short Term Effects of Public Smoking Bans on Health

Short Term Effects of Public Smoking Bans on Health

Features of ischemic heart disease and myocardial revascularization in patients younger than 40 years

Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome

Contact Info

Product

Resources

About